EA201990762A1 - METHODS FOR TREATING FEMALE INFERTILITY - Google Patents
METHODS FOR TREATING FEMALE INFERTILITYInfo
- Publication number
- EA201990762A1 EA201990762A1 EA201990762A EA201990762A EA201990762A1 EA 201990762 A1 EA201990762 A1 EA 201990762A1 EA 201990762 A EA201990762 A EA 201990762A EA 201990762 A EA201990762 A EA 201990762A EA 201990762 A1 EA201990762 A1 EA 201990762A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- methods
- provides
- female infertility
- treating female
- pregnancy
- Prior art date
Links
Abstract
Дополнительно, в соответствии с данным изобретением, предусматриваются способы промотирования созревания яйцеклетки во вспомогательных репродуктивных технологиях, таких как in vitro оплодотворение (ЭКО) или в процессе переноса эмбриона (ПЭ). Также предусматриваются способы снижения частоты синдрома гиперстимуляции яичников (СГЯ), что обеспечивает сопоставимую или повышенную частоту наступления беременности, уменьшает время до наступления беременности и ингибирует преждевременную овуляцию. Указанные способы включают стадию введения терапевтически эффективного количества активного фармацевтического ингредиента 2-(N-ацетил-D-тирозил-транс-4-гидрокси-L-пролил-L-аспарагинил-L-треонил-L-фенилаланил)гидразинокарбонил-L-лейцил-Nro-метил-L-аргинил-L-триптофанамида или его фармацевтически приемлемой соли.Additionally, in accordance with this invention, methods are provided for promoting egg maturation in assisted reproductive technologies such as in vitro fertilization (IVF) or during embryo transfer (PE). It also provides methods to reduce the frequency of ovarian hyperstimulation syndrome (OHSS), which provides a comparable or increased pregnancy rate, reduces the time before pregnancy and inhibits premature ovulation. These methods include the step of administering a therapeutically effective amount of the active pharmaceutical ingredient 2- (N-acetyl-D-tyrosyl-trans-4-hydroxy-L-prolyl-L-asparaginyl-L-threonyl-L-phenylalanyl) hydrazinocarbonyl-L-leucyl- Nro-methyl-L-arginyl-L-tryptophanamide or a pharmaceutically acceptable salt thereof.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201662402018P | 2016-09-30 | 2016-09-30 | |
PCT/EP2017/074800 WO2018060438A1 (en) | 2016-09-30 | 2017-09-29 | Methods of treating female infertility |
Publications (1)
Publication Number | Publication Date |
---|---|
EA201990762A1 true EA201990762A1 (en) | 2019-12-30 |
Family
ID=66326333
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201990762A EA201990762A1 (en) | 2016-09-30 | 2017-09-29 | METHODS FOR TREATING FEMALE INFERTILITY |
Country Status (2)
Country | Link |
---|---|
AR (1) | AR110636A1 (en) |
EA (1) | EA201990762A1 (en) |
-
2017
- 2017-09-29 EA EA201990762A patent/EA201990762A1/en unknown
- 2017-09-29 AR ARP170102713A patent/AR110636A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
AR110636A1 (en) | 2019-04-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA202202097B (en) | Amino pyrimidine ssao inhibitors | |
MX2021004110A (en) | Pharmaceutical compositions comprising n-(3,5-dimethoxyphenyl)-n' -(1-methylethyl)-n-[3-(1-methyl-1h-pyrazol-4-yl)quinoxalin-6-yl] ethane-1,2-diamine. | |
EA201890725A1 (en) | PHARNESIDE X-RECEPTOR AGONISTS AND THEIR APPLICATION | |
EA201790078A1 (en) | MNK INHIBITORS AND RELATED METHODS | |
MX2019009501A (en) | Amino pyrimidine compounds useful as ssao inhibitors. | |
TR201901312T4 (en) | Tetrahydronaphthalene derivatives that inhibit the Mcl-1 protein. | |
PH12020550256A1 (en) | 1-benzyl-2-imino-4-phenyl-5-oxoimidazolidine derivatives as hiv protease inhibitors | |
MX2023002507A (en) | Cd73 inhibitors. | |
MX2021002321A (en) | Novel methods. | |
MX2019008875A (en) | Crac channel inhibitor compositions. | |
MX2017009417A (en) | Solid forms of 2-(5-(3-fluorophenyl)-3-hydroxypicolinamido)acetic acid, compositions, and uses thereof. | |
CL2018001830A1 (en) | Formulations of 2- (4-chlorophenyl) -n - ((2- (2,6-dioxopiperidin-3-yl) -1-oxoisoindolin-5-yl) methyl) -2,2-difluoroacetamide | |
PH12019502150A1 (en) | Compounds and methods for the treatment of parasitic diseases | |
CL2019002325A1 (en) | Pharmaceutical combinations to treat cancer. | |
CR20210480A (en) | Pharmaceutical formulations | |
AU2024202380A1 (en) | Methods of preventing or treating ophthalmic diseases | |
MX2021002322A (en) | Novel methods. | |
MX2018015353A (en) | Therapeutic uses of a c-raf inhibitor. | |
EA035519B9 (en) | 1,3,4-thiadiazole compounds and their use in treating cancer | |
EA202090164A1 (en) | Isotretinoin oral-mucous compositions and methods for their use | |
EA201990762A1 (en) | METHODS FOR TREATING FEMALE INFERTILITY | |
MX2019015280A (en) | Statin compositions and methods for use in treating synucleinopathies. | |
EA202090346A1 (en) | METHOD FOR PREPARING N - ((1R, 2S, 5R) -5- (TET-BUTYLAMINO) -2 - ((S) -3- (7-TET-BUTYLPYRAZOLO [1,5-a] [1,3,5] TRIAZIN-4-ILAMINO) -2-OXOPYRROLIDIN-1-YL) CYCLOHEXYL) ACETAMIDE | |
MX2018012952A (en) | Ophthalmic composition comprising a synergistic combination of glycogen and hyaluronic acid or a salt thereof. | |
CL2019002239A1 (en) | Pediatric Cancer Treatment Methods. (divisional request 201802807) |